| Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead WH Goodson III, L Lowe, DO Carpenter, M Gilbertson, A Manaf Ali, ... Carcinogenesis 36 (Suppl_1), S254-S296, 2015 | 338 | 2015 |
| Linking mechanistic and behavioral responses to sublethal esfenvalerate exposure in the endangered delta smelt; Hypomesus transpacificus (Fam. Osmeridae) RE Connon, J Geist, J Pfeiff, AV Loguinov, LS D'Abronzo, H Wintz, ... BMC genomics 10, 1-18, 2009 | 111 | 2009 |
| AKR1C3 promotes AR-V7 protein stabilization and confers resistance to AR-targeted therapies in advanced prostate cancer C Liu, JC Yang, CM Armstrong, W Lou, L Liu, X Qiu, B Zou, AP Lombard, ... Molecular cancer therapeutics 18 (10), 1875-1886, 2019 | 55 | 2019 |
| Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death KB Narayanan, M Ali, BJ Barclay, Q Cheng, L D’Abronzo, ... Carcinogenesis 36 (Suppl_1), S89-S110, 2015 | 55 | 2015 |
| Transcription Profiling in Environmental Diagnostics: Health Assessments in Columbia River Basin Steelhead (Oncorhynchus mykiss) RE Connon, LS D’Abronzo, NJ Hostetter, A Javidmehr, DD Roby, ... Environmental science & technology 46 (11), 6081-6087, 2012 | 50 | 2012 |
| Cross-resistance among next-generation antiandrogen drugs through the AKR1C3/AR-V7 axis in advanced prostate cancer J Zhao, S Ning, W Lou, JC Yang, CM Armstrong, AP Lombard, ... Molecular cancer therapeutics 19 (8), 1708-1718, 2020 | 48 | 2020 |
| Sublethal responses to ammonia exposure in the endangered delta smelt; Hypomesus transpacificus (Fam. Osmeridae) RE Connon, LA Deanovic, EB Fritsch, LS D’Abronzo, I Werner Aquatic toxicology 105 (3-4), 369-377, 2011 | 47 | 2011 |
| Linking molecular biomarkers with higher level condition indicators to identify effects of copper exposures on the endangered delta smelt (Hypomesus transpacificus) RE Connon, S Beggel, LS D'Abronzo, JP Geist, J Pfeiff, AV Loguinov, ... Environmental Toxicology and Chemistry 30 (2), 290-300, 2011 | 47 | 2011 |
| The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer LS D'Abronzo, S Bose, ME Crapuchettes, RE Beggs, RL Vinall, ... Oncogene 36 (46), 6359-6373, 2017 | 42 | 2017 |
| eIF4E phosphorylation in prostate cancer LS D'Abronzo, PM Ghosh Neoplasia 20 (6), 563-573, 2018 | 40 | 2018 |
| Overexpressed ABCB1 induces olaparib-taxane cross-resistance in advanced prostate cancer AP Lombard, C Liu, CM Armstrong, LS D'Abronzo, W Lou, H Chen, ... Translational oncology 12 (7), 871-878, 2019 | 27 | 2019 |
| Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer RM Savoy, L Chen, S Siddiqui, FU Melgoza, B Durbin-Johnson, C Drake, ... Endocrine-related cancer 22 (3), 369-386, 2015 | 21 | 2015 |
| Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase MK Jathal, TM Steele, S Siddiqui, BA Mooso, LS D’Abronzo, CM Drake, ... British journal of cancer 121 (3), 237-248, 2019 | 18 | 2019 |
| Steroid sulfatase stimulates intracrine androgen synthesis and is a therapeutic target for advanced prostate cancer CM Armstrong, C Liu, L Liu, JC Yang, W Lou, R Zhao, S Ning, ... Clinical Cancer Research 26 (22), 6064-6074, 2020 | 17 | 2020 |
| Wntless promotes cellular viability and resistance to enzalutamide in castration-resistant prostate cancer cells AP Lombard, C Liu, CM Armstrong, LS D’Abronzo, W Lou, CP Evans, ... American journal of clinical and experimental urology 7 (4), 203, 2019 | 14 | 2019 |
| Analysis of polymorphisms of TNF‐α, LT‐α, IL‐10, IL‐12 and CTLA‐4 in patients with warm autoimmune haemolytic anaemia LS D’ABRONZO, MMO Barros, JO Bordin, MS Figueiredo International Journal of Laboratory Hematology 34 (4), 356-361, 2012 | 14 | 2012 |
| Activation of the ABCB1 Amplicon in Docetaxel- and Cabazitaxel-Resistant Prostate Cancer Cells AP Lombard, W Lou, CM Armstrong, LS D'Abronzo, S Ning, CP Evans, ... Molecular cancer therapeutics 20 (10), 2061-2070, 2021 | 12 | 2021 |
| Cytochrome P4501A mRNA and protein induction in striped bass (Morone saxatilis) EDH Durieux, RE Connon, I Werner, LS D’Abronzo, PS Fitzgerald, ... Fish physiology and biochemistry 38, 1107-1116, 2012 | 9 | 2012 |
| Olaparib-Induced Senescence Is Bypassed through G2–M Checkpoint Override in Olaparib-Resistant Prostate Cancer AP Lombard, CM Armstrong, LS D'Abronzo, S Ning, AR Leslie, M Sharifi, ... Molecular cancer therapeutics 21 (4), 677-685, 2022 | 7 | 2022 |
| Bioengineered BERA-Wnt5a siRNA targeting Wnt5a/FZD2 signaling suppresses advanced prostate cancer tumor growth and enhances enzalutamide treatment S Ning, C Liu, W Lou, JC Yang, AP Lombard, LS D'Abronzo, N Batra, ... Molecular cancer therapeutics 21 (10), 1594-1607, 2022 | 5 | 2022 |
Allen C GaoUniversity of Califormia DavisVerified email at ucdavis.edu
